Our Group’s Purpose is to contribute to the enrichment of quality of life around the world, and core to all of our activities is our “Passion for Innovation. Compassion for Patients.®“ as reflected in our corporate slogan. Our commitment to support patients to find hope in their treatment drives all of our corporate activities. We are engaged in our activities with the belief that innovation will come from trials and errors and the continuous search for new medicines.
In order to further strengthen our global cross-functional initiatives, from April 2024, the Patient Centricity Special Assignment is responsible for overseeing and promoting the Group's patient centricity initiatives in an integrated manner. Moreover, to make innovation more meaningful, we will further foster a patient centric mindset throughout the entire Group by continually engaging with patients and listening to their experiences, challenges, and perspectives.
We will continuet to strengthen our efforts to move toward patient centricity throughout our entire value chain.